171 related articles for article (PubMed ID: 37274290)
1. Failure pattern and radiotherapy exploration in malignant pleural effusion non-small cell lung cancer treated with targeted therapy.
Li Q; Hu C; Su S; Ma Z; Geng Y; Hu Y; Li H; Lu B
Front Oncol; 2023; 13():974735. PubMed ID: 37274290
[TBL] [Abstract][Full Text] [Related]
2. Impact of thoracic tumor radiotherapy on survival in non-small-cell lung cancer with malignant pleural effusion treated with targeted therapy: Propensity score matching study.
Li Q; Hu C; Su S; Ma Z; Geng Y; Hu Y; Jin H; Li H; Lu B
Cancer Med; 2023 Jul; 12(14):14949-14959. PubMed ID: 37288833
[TBL] [Abstract][Full Text] [Related]
3. Non-Small Cell Lung Cancer with Malignant Pleural Effusion May Require Primary Tumor Radiotherapy in Addition to Drug Treatment.
Li Q; Hu C; Su S; Ma Z; Geng Y; Hu Y; Li H; Lu B
Cancer Manag Res; 2022; 14():3347-3358. PubMed ID: 36465711
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations.
Schwalk AJ; Ost DE; Saltijeral SN; De La Garza H; Casal RF; Jimenez CA; Eapen GA; Lewis J; Rinsurongkawong W; Rinsurongkawong V; Lee J; Elamin Y; Zhang J; Roth JA; Swisher S; Heymach JV; Grosu HB
Chest; 2021 Mar; 159(3):1256-1264. PubMed ID: 33217413
[TBL] [Abstract][Full Text] [Related]
5. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
[TBL] [Abstract][Full Text] [Related]
6. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of intrapleural hyperthermic perfusion in patients with malignant pleural effusion undergoing video-assisted thoracic surgery: a single-arm clinical trial.
Wang X; Kong M; Jin J; Lin Y; Jia L; Ye M
J Thorac Dis; 2022 May; 14(5):1497-1503. PubMed ID: 35693629
[TBL] [Abstract][Full Text] [Related]
8. Drug-eluting beads bronchial arterial chemoembolization plus intercostals arterial infusion chemotherapy is effective and well-tolerated in treating non-small cell lung cancer patients with refractory malignant pleural effusion.
Liu X; Lin H; Wang Q; Mu M; Pan P; Tian F; Zhang R; Zhao W; Bao P
J Thorac Dis; 2021 Apr; 13(4):2339-2350. PubMed ID: 34012583
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.
Morgensztern D; Waqar S; Subramanian J; Trinkaus K; Govindan R
J Thorac Oncol; 2012 Oct; 7(10):1485-9. PubMed ID: 22982649
[TBL] [Abstract][Full Text] [Related]
11. Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion.
Shan Y; Ding H; Lu J; Ge Z; Tan Y
Oncotarget; 2017 Dec; 8(68):112809-112815. PubMed ID: 29348867
[TBL] [Abstract][Full Text] [Related]
12. Radical aggressive treatment among non-small cell lung cancer patients with malignant pleural effusion without extra-thoracic disease.
Arrieta O; Escamilla-López I; Lyra-González I; Barrón F; Ramírez-Tirado LA; Vergara E; Corona-Cruz JF; Maldonado F; Jiménez-Fuentes E
J Thorac Dis; 2019 Feb; 11(2):595-601. PubMed ID: 30963004
[TBL] [Abstract][Full Text] [Related]
13. Detecting EGFR mutations and ALK/ROS1 rearrangements in non-small cell lung cancer using malignant pleural effusion samples.
Yao Y; Peng M; Shen Q; Hu Q; Gong H; Li Q; Zheng Z; Xu B; Li Y; Dong Y
Thorac Cancer; 2019 Feb; 10(2):193-202. PubMed ID: 30565433
[TBL] [Abstract][Full Text] [Related]
14. Better effect of intrapleural perfusion with hyperthermic chemotherapy by video-assisted thoracoscopic surgery for malignant pleural effusion treatment compared to normothermic chemoperfusion of the pleural cavity.
Cao Y; Zhang Q; Huang Z; Chai Z; Liu J; Wang J; Sun Z; Zhao T; Wang G; Chen G; Han Y; Li Q; Hong X
Cancer Med; 2022 Jan; 11(2):348-357. PubMed ID: 34854253
[TBL] [Abstract][Full Text] [Related]
15. Clinical course of asymptomatic malignant pleural effusion in non-small cell lung cancer patients: A multicenter retrospective study.
Roh J; Ahn HY; Kim I; Son JH; Seol HY; Kim MH; Lee MK; Eom JS
Medicine (Baltimore); 2021 May; 100(19):e25748. PubMed ID: 34106603
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for symptomatic malignant pleural effusion recurrence in patients with actionable mutations in advanced lung adenocarcinoma.
Xu K; Wu X; Chen L; Xie J; Hua X; Chen M; Jiang Y; Liu H; Zhang F; Lv T; Song Y; Zhan P
Transl Lung Cancer Res; 2023 Sep; 12(9):1887-1895. PubMed ID: 37854163
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of bevacizumab combined with chemotherapy in lung adenocarcinoma-induced malignant pleural effusion.
Tao H; Meng Q; Li M; Shi L; Tang J; Liu Z
Thorac Cancer; 2018 Feb; 9(2):298-304. PubMed ID: 29297985
[TBL] [Abstract][Full Text] [Related]
18. Clinical course of non-small cell lung cancer patients with dry pleural dissemination: Retrospective observational study.
Kim W; Park IK; Park S; Kang CH; Kim YT
Medicine (Baltimore); 2020 Mar; 99(11):e19533. PubMed ID: 32176106
[TBL] [Abstract][Full Text] [Related]
19. Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion.
Kitamura K; Kubota K; Ando M; Takahashi S; Nishijima N; Sugano T; Toyokawa M; Miwa K; Kosaihira S; Noro R; Minegishi Y; Seike M; Yoshimura A; Gemma A
Cancer Chemother Pharmacol; 2013 Feb; 71(2):457-61. PubMed ID: 23178954
[TBL] [Abstract][Full Text] [Related]
20. Intrapleural infusion of tumor cell-derived microparticles packaging methotrexate or saline combined with pemetrexed-cisplatin chemotherapy for the treatment of malignant pleural effusion in advanced non-squamous non-small cell lung cancer: A double-blind, randomized, placebo-controlled study.
Dong X; Huang Y; Yi T; Hu C; Gao Q; Chen Y; Zhang J; Chen J; Liu L; Meng R; Zhang S; Dai X; Fei S; Jin Y; Yin P; Hu Y; Wu G
Front Immunol; 2022; 13():1002938. PubMed ID: 36275698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
